Skip to main content
Top
Published in: Reactions Weekly 1/2024

01-01-2024 | Cabozantinib | Case report

Cabozantinib

Hypothyroidism

Published in: Reactions Weekly | Issue 1/2024

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Kanzaki H, et al. Cabozantinib for Advanced Hepatocellular Carcinoma in the Latest Real-World Practice: A Multicenter Retrospective Analysis. Drugs - Real World Outcomes 10: 513-520, Dec 2023. Available from: URL: https://dx.doi.org/10.1007/s40801-023-00379-x Kanzaki H, et al. Cabozantinib for Advanced Hepatocellular Carcinoma in the Latest Real-World Practice: A Multicenter Retrospective Analysis. Drugs - Real World Outcomes 10: 513-520, Dec 2023. Available from: URL: https://​dx.​doi.​org/​10.​1007/​s40801-023-00379-x
Metadata
Title
Cabozantinib
Hypothyroidism
Publication date
01-01-2024
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2024
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-52569-4

Other articles of this Issue 1/2024

Reactions Weekly 1/2024 Go to the issue

Case report

Antituberculars

Case report

Sugammadex